Pulmonary complications of COVID-19 in patients with diabetes
BACKGROUND. The coronavirus disease (COVID-19), caused by the SARS-CoV-2 coronavirus, continues to pose a serious threat to global health. One of the key characteristic of this disease is its ability to attack the respiratory system, which can lead to pneumonia, especially in severe cases. Patients...
Saved in:
Main Authors: | A.V. Garnytska (Author), O.S. Orlyk (Author) |
---|---|
Format: | Book |
Published: |
Civic Union "Communicable Diseases Intensive Care Association",
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endocrine side effects of immunotherapeutic drugs
by: O.S. Orlyk, et al.
Published: (2023) -
Endocrine pathologies in the conditions of chemotherapy
by: A.V. Garnytska, et al.
Published: (2023) -
MODY diabetes as an orphan disease: literature review
by: A.V. Garnytska, et al.
Published: (2024) -
Features of immune status in patients with pulmonary tuberculosis after the COVID-19
by: Yu.O. Matviienko, et al.
Published: (2024) -
Pathophysiological mechanisms of coronavirus disease (COVID-19) progression and fatal complications in patients with diabetes
by: T. O. Briukhanova, et al.
Published: (2020)